SAN FRANCISCO, May 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Get key insights from Forward Air's Q1 2025 earnings call: revenue, EBITDA growth, pricing strategies, and steps towards their $5 billion target.

Activist investor Ancora Holdings wants to shake up the board at Forward Air , saying three directors need to be removed ...

Activist investor Ancora Holdings Group is asking Forward Air’s shareholders to vote against three board members at the ...

CEO Sam Altman says “we want to build a brain for the world and make it super easy for people to use for whatever they want.” ...

CEO Sam Altman published a letter announcing the plan on Monday.